LTF and neoplasm: Adoptive transfer of DXM/lactoferrin PMN-MDSCs, Con PMN-MDSCs, or tumor PMN-MDSCs were conducted i.v. during OVA challenge, with PBS and DXM treatment serving as controls (Fig. 7a).